Real World Outcomes, Commercialization and Communications
SIRO helps its clients to take data driven decisions to deal with uncertainties and to
ensure affordable and effective healthcare to all. By influencing market strategies,
we help pharma companies to leverage the right value of their innovations
Expertise in real world data collection and analysis
Connects with investigators and engagements with hospitals help us generate prospective real world data and accessing healthcare data for retrospective analysis.
Analysts specially trained to cater different needs
Analysts with public health and epidemiology background trained on regression analysis, survival analysis, meta-analysis and pharmacoeconomic modelling.
Specialized writers
Dedicated writers for real world evidence and outcomes research publications (link to publications page); expertise in value communications.
Competence exhibition at global platforms
Regular presentations at ISMPP/ISPOR, webinars and workshops.
Services
Health economics and outcomes research
Systematic Literature Review Reimbursement landscape analysis Secondary data analysis Economic modelling consulting Patient reported outcomes
Real World Research
Prospective data generation Patient registries Health records Data analytics Patient and physician surveys Late phase effectiveness studies
Communications
Publications Global Value dossiers AMCP dossiers Systematic literature review reports White papers Trainings/workshops/CME
Case Studies
REAL WORLD OUTCOME CASE STUDY 1
As a part of market access strategy, client wanted to defend their product pipeline for a particular disease area.
REAL WORLD OUTCOME CASE STUDY 2
The client was facing challenges related to the market access of their pain management portfolio.
REAL WORLD OUTCOME CASE STUDY 3
A pharma giant wanted to launch their new Drug to 9 different countries of Asia-Pacific market.
REAL WORLD OUTCOME CASE STUDY 4
A client wanted to run a market-specific cost-effectiveness model for a treatment.